Cargando…

Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study

PURPOSE: Daily quantitative MR imaging during radiotherapy of cancer patients has become feasible with MRI systems integrated with linear accelerators (MR-linacs). Quantitative images could be used for treatment response monitoring. With intravoxel incoherent motion (IVIM) MRI, it is possible to acq...

Descripción completa

Detalles Bibliográficos
Autores principales: Kooreman, Ernst S., van Houdt, Petra J., Keesman, Rick, van Pelt, Vivian W. J., Nowee, Marlies E., Pos, Floris, Sikorska, Karolina, Wetscherek, Andreas, Müller, Arndt-Christian, Thorwarth, Daniela, Tree, Alison C., van der Heide, Uulke A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415108/
https://www.ncbi.nlm.nih.gov/pubmed/34485138
http://dx.doi.org/10.3389/fonc.2021.705964
_version_ 1783747906004582400
author Kooreman, Ernst S.
van Houdt, Petra J.
Keesman, Rick
van Pelt, Vivian W. J.
Nowee, Marlies E.
Pos, Floris
Sikorska, Karolina
Wetscherek, Andreas
Müller, Arndt-Christian
Thorwarth, Daniela
Tree, Alison C.
van der Heide, Uulke A.
author_facet Kooreman, Ernst S.
van Houdt, Petra J.
Keesman, Rick
van Pelt, Vivian W. J.
Nowee, Marlies E.
Pos, Floris
Sikorska, Karolina
Wetscherek, Andreas
Müller, Arndt-Christian
Thorwarth, Daniela
Tree, Alison C.
van der Heide, Uulke A.
author_sort Kooreman, Ernst S.
collection PubMed
description PURPOSE: Daily quantitative MR imaging during radiotherapy of cancer patients has become feasible with MRI systems integrated with linear accelerators (MR-linacs). Quantitative images could be used for treatment response monitoring. With intravoxel incoherent motion (IVIM) MRI, it is possible to acquire perfusion information without the use of contrast agents. In this multicenter study, daily IVIM measurements were performed in prostate cancer patients to identify changes that potentially reflect response to treatment. MATERIALS AND METHODS: Forty-three patients were included, treated with 20 fractions of 3 Gy on a 1.5 T MR-linac. IVIM measurements were performed on each treatment day. The diffusion coefficient (D), perfusion fraction (f), and pseudo-diffusion coefficient (D*) were calculated based on the median signal intensities in the non-cancerous prostate and the tumor. Repeatability coefficients (RCs) were determined based on the first two treatment fractions. Separate linear mixed-effects models were constructed for the three IVIM parameters. RESULTS: In total, 726 fractions were analyzed. Pre-treatment average values, measured on the first fraction before irradiation, were 1.46 × 10(−3) mm(2)/s, 0.086, and 28.7 × 10(−3) mm(2)/s in the non-cancerous prostate and 1.19 × 10(−3) mm(2)/s, 0.088, and 28.9 × 10(−3) mm(2)/s in the tumor, for D, f, and D*, respectively. The repeatability coefficients for D, f, and D* in the non-cancerous prostate were 0.09 × 10(−3) mm(2)/s, 0.05, and 15.3 × 10(−3) mm(2)/s. In the tumor, these values were 0.44 × 10(−3) mm(2)/s, 0.16, and 76.4 × 10(−3) mm(2)/s. The mixed effects analysis showed an increase in D of the tumors over the course of treatment, while remaining stable in the non-cancerous prostate. The f and D* increased in both the non-cancerous prostate and tumor. CONCLUSIONS: It is feasible to perform daily IVIM measurements on an MR-linac system. Although the repeatability coefficients were high, changes in IVIM perfusion parameters were measured on a group level, indicating that IVIM has potential for measuring treatment response.
format Online
Article
Text
id pubmed-8415108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84151082021-09-04 Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study Kooreman, Ernst S. van Houdt, Petra J. Keesman, Rick van Pelt, Vivian W. J. Nowee, Marlies E. Pos, Floris Sikorska, Karolina Wetscherek, Andreas Müller, Arndt-Christian Thorwarth, Daniela Tree, Alison C. van der Heide, Uulke A. Front Oncol Oncology PURPOSE: Daily quantitative MR imaging during radiotherapy of cancer patients has become feasible with MRI systems integrated with linear accelerators (MR-linacs). Quantitative images could be used for treatment response monitoring. With intravoxel incoherent motion (IVIM) MRI, it is possible to acquire perfusion information without the use of contrast agents. In this multicenter study, daily IVIM measurements were performed in prostate cancer patients to identify changes that potentially reflect response to treatment. MATERIALS AND METHODS: Forty-three patients were included, treated with 20 fractions of 3 Gy on a 1.5 T MR-linac. IVIM measurements were performed on each treatment day. The diffusion coefficient (D), perfusion fraction (f), and pseudo-diffusion coefficient (D*) were calculated based on the median signal intensities in the non-cancerous prostate and the tumor. Repeatability coefficients (RCs) were determined based on the first two treatment fractions. Separate linear mixed-effects models were constructed for the three IVIM parameters. RESULTS: In total, 726 fractions were analyzed. Pre-treatment average values, measured on the first fraction before irradiation, were 1.46 × 10(−3) mm(2)/s, 0.086, and 28.7 × 10(−3) mm(2)/s in the non-cancerous prostate and 1.19 × 10(−3) mm(2)/s, 0.088, and 28.9 × 10(−3) mm(2)/s in the tumor, for D, f, and D*, respectively. The repeatability coefficients for D, f, and D* in the non-cancerous prostate were 0.09 × 10(−3) mm(2)/s, 0.05, and 15.3 × 10(−3) mm(2)/s. In the tumor, these values were 0.44 × 10(−3) mm(2)/s, 0.16, and 76.4 × 10(−3) mm(2)/s. The mixed effects analysis showed an increase in D of the tumors over the course of treatment, while remaining stable in the non-cancerous prostate. The f and D* increased in both the non-cancerous prostate and tumor. CONCLUSIONS: It is feasible to perform daily IVIM measurements on an MR-linac system. Although the repeatability coefficients were high, changes in IVIM perfusion parameters were measured on a group level, indicating that IVIM has potential for measuring treatment response. Frontiers Media S.A. 2021-08-13 /pmc/articles/PMC8415108/ /pubmed/34485138 http://dx.doi.org/10.3389/fonc.2021.705964 Text en Copyright © 2021 Kooreman, van Houdt, Keesman, van Pelt, Nowee, Pos, Sikorska, Wetscherek, Müller, Thorwarth, Tree and van der Heide https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kooreman, Ernst S.
van Houdt, Petra J.
Keesman, Rick
van Pelt, Vivian W. J.
Nowee, Marlies E.
Pos, Floris
Sikorska, Karolina
Wetscherek, Andreas
Müller, Arndt-Christian
Thorwarth, Daniela
Tree, Alison C.
van der Heide, Uulke A.
Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study
title Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study
title_full Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study
title_fullStr Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study
title_full_unstemmed Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study
title_short Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy—A Multicenter Study
title_sort daily intravoxel incoherent motion (ivim) in prostate cancer patients during mr-guided radiotherapy—a multicenter study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415108/
https://www.ncbi.nlm.nih.gov/pubmed/34485138
http://dx.doi.org/10.3389/fonc.2021.705964
work_keys_str_mv AT kooremanernsts dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT vanhoudtpetraj dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT keesmanrick dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT vanpeltvivianwj dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT noweemarliese dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT posfloris dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT sikorskakarolina dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT wetscherekandreas dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT mullerarndtchristian dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT thorwarthdaniela dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT treealisonc dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy
AT vanderheideuulkea dailyintravoxelincoherentmotioniviminprostatecancerpatientsduringmrguidedradiotherapyamulticenterstudy